Objective: The ventromedial hypothalamic nucleus (VMH) regulates energy balance and glucose homeostasis. Leptin and insulin exert metabolic effects via their cognate receptors expressed by the steroidogenic factor 1 (SF1) neurons within the VMH. However, detailed cellular mechanisms involved in the regulation of these neurons by leptin and insulin remain to be identified. Methods: We utilized genetically-modified mouse models and performed patch-clamp electrophysiology experiments to resolve this issue. Results: We identified distinct populations of leptin-activated and leptin-inhibited SF1 neurons. In contrast, insulin uniformly inhibited SF1 neurons. Notably, we found that leptin-activated, leptin-inhibited, and insulin-inhibited SF1 neurons are distinct subpopulations within the VMH. Leptin depolarization of SF1 neuron also required the PI3K p110b catalytic subunit. This effect was mediated by the putative transient receptor potential C (TRPC) channel. On the other hand, hyperpolarizing responses of SF1 neurons by leptin and insulin required either of the p110a or p110b catalytic subunits, and were mediated by the putative ATP-sensitive K þ (K ATP ) channel.
INTRODUCTION
The ventromedial nucleus of hypothalamus (VMH) has long been recognized as a brain site that regulates energy balance [1] . The expression of nuclear receptor, steroidogenic factor 1 (SF1), is highly restricted to the VMH and is critical for its development [2] . Notably, SF1-expressing neurons within VMH (VMH SF1 neurons) regulate energy balance and glucose homeostasis [3, 4] . SF1 neurons express both leptin receptors (LepRs) and insulin receptors (InsRs). Deficiency of LepRs or InsRs selectively in SF1 neurons results in opposite body weight phenotypes. In particular, SF1-specific LepR deficiency results in obesity when challenged with high fat diet (HFD) [5, 6] . Inversely, loss of InsR in SF1 neurons protects against HFD-induced obesity [7] . These results are somewhat paradoxical as both receptors are known to activate phosphatidylinositol-3-kinase (PI3K)-dependent intracellular signaling pathways [8e10] . These observations may be explained in part by the findings that leptin acutely activates (or depolarizes) while insulin acutely inhibits (or hyperpolarizes) SF1 neurons [5, 7] . Moreover, we cannot exclude the role of PI3K-dependent regulation of genomic pathways (e.g. FOXO1 signaling), which are similarly activated by leptin and insulin and may also play a determining role in chronic metabolic phenotypes [11] . Notably, the acute (and possibly chronic) effects of leptin and insulin are segregated to distinct subpopulations of VMH SF1 neurons [7] , supporting functionally heterogeneous SF1 neurons, which independently may contribute to different facets of metabolism. However, detailed cellular mechanisms that underlie the distinct actions of leptin and insulin on VMH SF1 neurons still remain to be identified. PI3K functions as heterodimers that consist of the 110 kDa catalytic subunits (p110a and p110b) and the 85 kDa regulatory subunits (p85a and p85b) [12] . Deletion of the regulatory PI3K subunits (p85a and p85b) in the arcuate pro-opiomelanocortin (POMC) neurons blunts the acute effects of both leptin and insulin [13] . Moreover, p110b isoform has a dominant role over p110a in mediating the acute effects of leptin and insulin in POMC neurons as well as in maintaining energy balance [14] . However, contribution of specific PI3K catalytic subunit 1 isoforms to the acute effects of leptin and insulin on VMH SF1 neurons remains undefined. In this study, we characterized the acute effects of leptin and insulin on VMH SF1 neurons and identified the role of specific PI3K catalytic subunit isoforms (p110a and p110b) in this response.
METHODS

Mice
Male (4e16 weeks old) pathogen-free SF1-cre mice [5] were crossed with either the Z/EG (GFP) reporter mice (Jackson Laboratory, # 003920) or the tdTomato reporter mice (Jackson Laboratory, #007908) to identify VMH SF1 neurons. For some experiments, SF1-cre::GFP or SF1-cre::tdTomato mice were crossed with either p110a flox/flox mice [15] or p110b flox/flox mice [16] to delete p110a or p110b specifically in SF1 neurons. All mice used in this study were housed in a lightedark ( 
Electrophysiology
Whole-cell patch-clamp recordings from SF1 neurons maintained in hypothalamic slice preparations and data analysis were performed as previously described [13, 17] . Briefly, 4-to 16-week-old male mice were deeply anesthetized with i.p. injection of 7% chloral hydrate or isoflurane inhalations and transcardially perfused with a modified icecold artificial CSF (ACSF) (described below), in which an equiosmolar amount of sucrose was substituted for NaCl. The mice were then decapitated, and the entire brain was removed and immediately submerged in ice-cold, carbogen-saturated (95% O 2 and 5% CO 2 ) ACSF (126 mM NaCl, 2.8 mM KCl, 1.2 mM MgCl 2 , 2.5 mM CaCl 2 , 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , and 5 mM glucose). A brain block containing the hypothalamus was made. Coronal sections (250 mm)
were cut with a Leica VT1000S or VT1200S Vibratome and then incubated in oxygenated ACSF at room temperature for at least 1 h before recording. Slices were transferred to the recording chamber and allowed to equilibrate for 10e20 min before recording. The slices were bathed in oxygenated ACSF (32 Ce34 C) at a flow rate of w2 ml/ min. The pipette solution for whole-cell recording was modified to include an intracellular dye (Alexa Fluor 594 or Alexa Fluor 488) for whole-cell recording: 120 mM K-gluconate, 10 mM KCl, 10 mM HEPES, 5 mM EGTA, 1 mM CaCl 2 , 1 mM MgCl 2 , and 2 mM MgATP, 0.03 mM Alexa Fluor 594 or Alexa Fluor 488 hydrazide dye, pH 7.3. Epifluorescence was briefly used to target fluorescent cells, at which time the light source was switched to infrared differential interference contrast imaging to obtain the whole cell recording (Zeiss Axioskop FS2 Plus equipped with a fixed stage and a QuantEM:512SC electronmultiplying charge-coupled device camera or Nikon Eclipse FN1 equipped with a fixed stage and an optiMOS scientific CMOS camera). Electrophysiological signals were recorded using an Axopatch 700B amplifier (Molecular Devices), low-pass filtered at 2e5 kHz, and analyzed offline on a PC with pCLAMP programs (Molecular Devices).
Recording electrodes had resistances of 2.5e5 MU when filled with the K-gluconate internal solution. Input resistance was assessed by measuring voltage deflection at the end of the response to a hyperpolarizing rectangular current pulse steps (500 ms of À10 to À50 pA). For some experiments measuring currentevoltage (IeV) relationships by applying ramp pulses in voltage clamp mode, the Kgluconate internal solution was replaced by Cs-glucoate and QX-314 (4 mM) was added. The extracellular solution for voltage clamp experiments contained 4-AP (5 mM), CdCl 2 (100 mM), CsCl (1 mM), and TTX (1 mM). Membrane potential values were compensated to account for junction potential (À8 mV). Leptin (100 nM; provided by A. F. Parlow, through the National Hormone and Peptide Program) and insulin (50 nM, Humulin-R 100 U/ml; Eli Lilly and Company) were added to the ACSF for specific experiments. Solutions containing leptin or insulin were typically perfused for 2e4 min. A drug effect was required to be associated temporally with peptide application, and the response had to be stable within a few minutes. A neuron was considered depolarized or hyperpolarized if a change in membrane potential was at least 2 mV in amplitude. After recording, slices were fixed with 4% formalin in PBS at 4 C overnight. After washing in PBS, slices were mounted onto slides, covered in Vectashield (Vector Laboratories), and coverslipped to reduce photooxidation during visualization with fluorescent light. Cells were then visualized with ApoTome imaging system (Imager Z1; Zeiss) to identify post hoc the anatomical location of the recorded neuron.
2.3. Drugs SKF96365 and 2-APB were obtained from Tocris. LY294002 and wortmannin were obtained from Calbiochem. Tolbutamide was obtained from Sigma. All solutions were made according to manufacturer's specifications. Stock solutions of SKF96365, 2-APB, LY294002, and wortmannin were made by dissolution in DMSO (Sigma). The concentration of DMSO in the external solution was <0.1%. Stock solutions of tolbutamide were made by dissolution in 100% ethanol, with the final ethanol concentration in ACSF less than 0.5%. Stock solutions of leptin were made by dissolution in D-PBS (Gibco).
Data analysis
Statistical data are expressed as mean AE s.e.m., where n represents the number of cells studied. The significance of differences between was evaluated using unpaired 2-tailed Student's t test with a confidence level of p < 0.05 (*) or p < 0.01 (**).
RESULTS
Leptin either depolarizes or hyperpolarizes distinct subsets of VMH SF1 neurons
To identify the cellular mechanisms underlying the leptin-induced depolarization of VMH SF1 neurons, we targeted identified neurons from SF1-cre::green fluorescent protein (GFP) or SF1-cre::tdTomato mice and examined the acute responses to leptin application ( Figure 1 ). Similar to previous reports [5] , leptin (100 nM) reversibly depolarized a subset (14 of 80; 17.5%) of VMH SF1 neurons by 5.4 AE 0.3 mV (from À53.2 AE 1.1 mV to À47.8 AE 1.0 mV, n ¼ 14) ( Figure 1E , upper panel and Figure 1G ). The leptin-induced depolarization was accompanied by w20% decrease of input resistance (from 1,063.1 AE 63.9 MU to 844.9 AE 50.0 MU, n ¼ 14, Figure 1F and H) as measured by voltage responses to small hyperpolarizing current steps ( Figure 1E , lower panels and 1F). The reversal potential was calculated to be À30.5 AE 1.7 mV (n ¼ 14) ( Figure 1F ). These results suggested that leptin activates a putative non-selective (mixed) cation conductance to depolarize VMH SF1 neurons. We also found that bath application of leptin hyperpolarized a different subset (14 of 80; 17.5%) of SF1 neurons by À7.2 AE 0.5 mV (from À51.4 AE 0.7 mV to À58.7 AE 1.0 mV, n ¼ 14) ( Figure 1I , upper panel and Figure 1K ). The leptin-induced hyperpolarization was accompanied by w20% decrease of input resistance (from 801.3 AE 45.7 MU to 637.4 AE 37.7 MU, n ¼ 14, Figure 1J and L) as measured by voltage responses to small hyperpolarizing current steps ( Figure 1I , lower panels and 1J). The reversal potential was calculated to be À90.4 AE 3.0 mV (n ¼ 14) ( Figure 1J ). The leptin-induced hyperpolarization was fully reversed by tolbutamide, a specific blocker of ATP-sensitive K þ (K ATP ) channels ( Figure 1I ). These results suggested that leptin hyperpolarizes a subset of VMH SF1 neurons via activation of putative K ATP conductance. Following all recordings, the slices were fixed in order to identify the location of recorded SF1 neurons within the rostrocaudal and mediolateral axis of VMH ( Figure 2AeC ). Leptin-activated SF1 neurons were predominantly located within the dorsomedial subdivision of the VMH (dmVMH), as previously reported [5] ( Figure 2D ). In contrast, leptininhibited SF1 neurons were found to be scattered throughout the VMH ( Figure 2D ). These findings may explain the discrepancy between results from the current study and a previous study, which reported that 14 of 17 SF1 neurons are depolarized by leptin [5] . Based on our findings, we predict that these results reflect the fact that recordings were targeted in the dmVMH. Taken together, our results suggest that leptin-responsive SF1 neurons are heterogeneous in their location and acute responses to leptin (Table 1) . (100 mM), the I h blocker CsCl (1 mM), the Na channel blocker TTX (1 mM) were added to the external solution. At a holding potential of À60 mV, application of leptin induced inward currents of À15.3 AE 4.0 pA in 7 of 46 neurons tested ( Figure 3A ). Voltage ramp pulses (from À100 mV to þ100 mV in 2 s, 100 mV/s) were applied before and during leptin application to determine currentevoltage (IV) relationships of leptin-induced currents ( Figure 3B , averages of 7 traces). The subtracted current revealed a net outward-rectifying current, which is consistent with the activation of TRPC conductance [18, 19] ( Figure 3C , average of 7 subtracted traces). The remaining neurons were unaffected by leptin in this recording condition (À0.5 AE 0.6 pA, n ¼ 39). It should be noted that the percentage of leptin-responsive neurons (15.2%) are similar to those depolarized by leptin in the current clamp mode (17.5%). Analogous to leptinactivation, SF1 neurons that displayed a leptin-induced inward current were predominantly located within dmVMH ( Figure 3D ). Also, leptin failed to induce any outward currents, likely due to the presence of Cs þ in the pipette solution, which blocks potassium conductances.
Leptin activates TRPC channels to depolarize VMH SF1 neurons
We also performed a series of experiments using pharmacological inhibitors of TRPC channels. We found that pretreatment of cells with 2-APB completely blocked leptin-induced depolarization of SF1 neurons (0.2 AE 0.2 mV, n ¼ 14; Figure 3EeG ). Similarly, leptin failed to depolarize cells that were pretreated with SKF96365. Notably, the net effect of leptin in the presence of SKF96365 was hyperpolarizing ( Figure 3F ), as leptin hyperpolarized 3 of 11 cells (À7.7 AE 1.2 mV, n ¼ 3; Figure 3H ). The remaining cells were unchanged in response to leptin (À0.1 AE 0.4 mV, n ¼ 8; Figure 3H ). These results suggest that pharmacological antagonists of TRPC channels selectively abolish leptin-induced depolarization ( Figure 3EeH) ; however, the leptininduced hyperpolarization is not affected by TRPC channel blockade.
3.3. Leptin-induced depolarization specifically requires the p110b isoform The role of p110a isoform in VMH SF1 neurons in regulating in vivo energy balance has been assessed [15] . However, we currently do not know the roles of specific p110 isoforms in mediating the acute effects of leptin on SF1 neurons. Therefore, we assessed cellular responses in mice in which VMH SF1 neurons were deficient for either the p110a or p110b isoforms (sf1-cre::p110a flox/flox or sf1-cre::p110b flox/flox , respectively). Both types of leptin-induced acute responses (depolarization or hyperpolarization) were present in VMH SF1 neurons deficient for p110a ( Figure 4A and C, upper panels). In contrast, leptininduced depolarization was absent in VMH SF1 neurons deficient for p110b subunits ( Figure 4B and C, lower panels). We did observe that VMH SF1 neurons deficient for p110b subunits were hyperpolarized in response to leptin. Taken together, these data suggest that the p110b isoform of PI3K catalytic subunit is specifically required for leptininduced acute activation of VMH SF1 neurons. In contrast, deficiency of either p110a or p110b isoform alone is not sufficient to abolish the leptin-induced acute inhibition. The acute effects of leptin on p110a-or p110b-deficient VMH SF1 neurons are summarized in Table 1. 3.4. Insulin hyperpolarizes a subset of VMH SF1 neurons via p110a/p110b-dependent activation of K ATP channels Similar to previous reports [7] we found that insulin hyperpolarized a subset ( (from À52.6 AE 1.1 mV to À62.0 AE 2.0 mV, n ¼ 11) (Figure 5E and H). The insulin-induced hyperpolarization was accompanied by w25% decrease of input resistance (from 915.5 AE 63.5 MU to 692.1 AE 51.2 MU, n ¼ 11, Figure 5G and I) as measured by voltage responses to small hyperpolarizing current steps ( Figure 5F and G). The reversal potential was calculated to be À90.4 AE 3.1 mV (n ¼ 11) ( Figure 5G ). The insulin-induced hyperpolarization was also reversed by tolbutamide ( Figure 5E ), supporting a role for K ATP channels in the acute insulin-induced hyperpolarization of VMH SF1 neurons. The in vivo metabolic effects of insulin receptors expressed by VMH SF1 neurons are dependent on the activity of PI3Ks [7] . However, it's currently unknown whether specific PI3K catalytic subunit isoforms are involved in the acute effects of insulin. To determine which specific p110 isoforms are responsible for the acute effects of insulin, we assessed cellular responses of VMH SF1 neurons deficient for either p110a or p110b isoforms (sf1-cre::p110a flox/flox or sf1-cre::p110b flox/ flox , respectively). We found that neither p110a deletion nor p110b deletion affected the insulin-induced acute hyperpolarization of VMH SF1 neurons (Figure 5J to 5L; Table 1 ).
3.5. Acute inhibition of SF1 neurons by leptin and insulin is blocked by the deletion of both p110a and p110b isoforms Subsequently, we tested if pretreatment with pharmacological inhibitors of PI3K (10 mM LY294002 or 100 nM wortmannin) could block the acute effects of leptin and insulin. To this end, the cells were pretreated with 10 mM LY294002 for 10 min before applications of leptin or insulin. In this condition, neither leptin nor insulin affected the membrane potential of SF1 neurons (À0.4 AE 0.2 mV, n ¼ 9, for leptin and À0.4 AE 0.2 mV, n ¼ 9, for insulin, Figure 6A ). We found similar effects with 100 nM wortmannin pretreatment (À0.4 AE 0.1 mV, n ¼ 8, for leptin and À0.3 AE 0.1 mV, n ¼ 9, for insulin). In agreement with these data, both leptin and insulin failed to alter the membrane potential of VMH SF1 neurons deficient for both p110a and p110b (sf1-cre::p110a flox/flox , p110b flox/flox ; Figure 6B and C). Taken together, the acute depolarizing and hyperpolarizing effects of leptin and insulin on VMH SF1 neurons are dependent on PI3K activity. Our findings suggest that the acute depolarization by leptin is mediated by p110b while the acute hyperpolarization of membrane potential by leptin or insulin requires the presence of either p110a or p110b (Table 1 ).
3.6. Acute effects of leptin and insulin are anatomically segregated to distinct SF1 neuronal populations SF1 neuron-specific deletions of LepRs and InsRs have opposite effects on body weight regulation [5e7]. In addition, previous findings suggested that LepR-expressing and InsR-expressing SF1 neurons are segregated within the VMH [7] . We performed sequential applications of leptin and insulin to VMH SF1 neurons and characterized the acute responses in detail. In particular, leptin-activated SF1 neurons (5.4 AE 0.3 mV, n ¼ 3) did not respond to subsequent insulin application (À0.3 AE 0.2 mV, n ¼ 3, Figure 7A ). In addition, a subset of SF1 neurons that did not respond to leptin application (À0.5 AE 0.4 mV, n ¼ 6) was hyperpolarized by insulin (À7.7 AE 1.4 mV, n ¼ 6, Figure 7B ). Moreover, a group of SF1 neurons that did not respond to insulin (À0.3 AE 0.2 mV, n ¼ 6) were either hyperpolarized (À6.5 AE 1.2 mV, n ¼ 4, Figure 7C ) or depolarized (6 mV and 7 mV, trace not shown) by subsequent leptin application. The leptin-and insulin-induced acute hyperpolarization was not readily reversible so that we could not perform dual application experiments when we observed hyperpolarization in the first application. We further analyzed the sub-nuclear locations of each response within VMH and found the distribution of acute leptin and insulin responses are similar to those described in Figures 2D and 5L (Figure 7D ). Therefore, our findings suggest that VMH SF1 neurons are functionally heterogeneous in their response to leptin and insulin so that LepR-expressing SF1 neurons protect against HFD-induced obesity while InsR-expressing SF1 neurons promote obesity in HFD.
DISCUSSION
In the current study, we characterized the acute effects of leptin and insulin on VMH SF1 neurons and delineated the involvement of specific p110 isoforms. Briefly, leptin either depolarized or hyperpolarized SF1 neurons, while insulin consistently hyperpolarized a different subpopulation of SF1 neurons. The acute effects of leptin and insulin were dependent on PI3K activity, as their effects were completely abolished by the pretreatment with PI3K inhibitors or the deletion of both p110a and p110b isoforms. Interestingly, we found that the leptin-induced depolarization, which was mediated by TRPC channel activation, was solely dependent upon the PI3K p110b catalytic subunit. In contrast, the leptin-and insulin-induced hyperpolarization, which involved K ATP channel activation, was dependent on the presence of either p110a or p110b. Our electrophysiological data provide novel mechanistic insight into the cell biology that underlies functional heterogeneity of VMH SF1 neurons, which may underlie the differential effects on body weight regulation observed in SF1 neuron-specific deletion of LepR or InsR [5e7]. Insulin-induced acute inhibition was previously demonstrated in arcuate POMC neurons, arcuate NPY/AgRP neurons and VMH SF1
neurons [7,13,20e22] . These acute effects of insulin were shown to be mediated by a PI3K-dependent activation of K ATP channels. Deletion of InsRs specifically in SF1 neurons ameliorated the obese phenotype associated with HFD challenge [7] , which suggests that InsRs expressed by SF1 neurons promote obesity in HFD. As it was previously demonstrated that VMH and SF1 neurons send glutamatergic projections to arcuate POMC neurons [7, 23] , the acute inhibition of SF1 neurons by insulin could result in the suppression of an anorexigenic pathway from SF1 neuron to POMC neuron. Acute leptin effects on neuronal activity have previously been described in several distinct brain nuclei [24] . For instance, leptin depolarizes arcuate POMC neurons and PMV LepR neurons via PI3K-dependent activation of TRPC channels [13, 19, 25] . By contrast, neurons within the lateral hypothalamic area (LHA), dorsal motor nucleus of vagus nerve (DMV), and nucleus tractus solitarius (NTS) are hyperpolarized by leptin via the activation of K ATP channels [26e28]. Acute and chronic effects of leptin are mediated at least in part by the signaling pathways downstream of PI3K in hypothalamus [13e15]. Specifically, the deletion of both p85a and p85b regulatory subunits abolished acute leptin effects in arcuate POMC neurons [13] . In addition, the p110b catalytic subunits were shown to have dominant role over p110a isoforms to mediate the acute effects of leptin and insulin in arcuate POMC neurons [14] . However, the involvement of specific PI3K catalytic subunit isoforms in leptin-induced acute activation or inhibition has not yet been described in VMH SF1 neurons. In this study, we demonstrated that leptin depolarizes a subpopulation of SF1 neurons within the dmVMH and hyperpolarizes another subpopulation of SF1 neurons that are scattered throughout the VMH. It is of particular interest to note that leptin specifically recruits the p110b isoform to open TRPC channels and depolarize the membrane potential, while the leptin-induced activation of K ATP channels and resulting hyperpolarization requires either the p110a or p110b isoforms. These results highlight the existence of distinct coupling between specific p110 isoforms and ion channels within discrete subdivisions of VMH. It is notable that only p110b was found to mediate leptin-induced acute activation of SF1 neurons. Currently, we have not assessed in vivo metabolic effects in mice that lack p110b specifically in SF1 neurons. Nonetheless, we predict that p110b deletion in SF1 neurons, in contrast to p110a deletion, may significantly affect homeostatic regulation of blood glucose levels. This is because p110b mediates leptin-induced acute regulation of SF1 neuronal activity, which may be important for appropriately responding to changes in glucose level. It should be noted that SF1 neurons lacking p110b subunits have cell capacitance comparable to that of wildtype SF1 neurons. In this respect, leptin-activated SF1 neurons are confined to dmVMH, which was recently highlighted as a key brain area that mediates counterregulatory response (CRR) to hypoglycemia [29, 30] . In support of these data, a Cre-dependent viral tracing study demonstrated that SF1 neurons within the VMH project to the dorsal vagal complex (DVC), which is one of the autonomic centers that regulate blood glucose levels [31] . However, two studies have reported distinct roles of glutamatergic neurotransmission from SF1 neurons in CRR [32, 33] . Additional studies are warranted to define the role of specific subpopulations of SF1 neurons in maintaining glucose homeostasis. It was previously demonstrated that deletion of LepRs in VMH SF1 neurons led to obesity both in normal chow diet and HFD [5, 6] . The increased weight gain was largely dependent upon decreased energy expenditure independent of caloric intake [5] . Similarly, deletion of p110a in SF1 neurons resulted in impaired thermogenesis concomitant with obesity when exposed to HFD, independent of effects on food intake or glucose homeostasis [15] . These findings suggest that LepR/ p110a signaling in SF1 neurons may protect against HFD-induced obesity via increasing energy expenditure. It was previously predicted that leptin-induced activation of SF1 neurons is the cellular correlates for this effect [5] , however we found that p110a deletion in SF1 neurons does not prevent leptin-induced activation of SF1 neurons. Thus, our data suggest that chronic and/or genomic events downstream of LepR/p110a signaling (possibly independent of PI3K), rather than the leptin-induced acute activation, may be more important for protection against HFD-induced obesity. In support of this idea, we found that p110a-deficient SF1 neurons have smaller cell capacitance, indicative of a smaller cell size (Table 1) . This is consistent with previous reports that demonstrated that overexpression of PTEN or constitutively-active p110a leads to cardiac hypertrophy [34, 35] . Also, the overexpression of dominant-negative p110a results in smaller heart [35] . Thus, although p110a does not mediate acute activation of SF1 neurons by leptin, chronic genomic pathways downstream of LepR/p110a activation may contribute to the effects of leptin. LepRs and InsRs share multiple intracellular signaling molecules that control genomic pathways [36] . FOXO1 is a transcription factor that may regulate leptin and insulin activity in brain [37, 38] . Interestingly, deletion of FOXO1 specifically in SF1 neurons (SF1-cre::Foxo1 flox/flox ) resulted in a lean body weight phenotype due to increased energy expenditure [39] . SF1-cre::Foxo1 flox/flox mice showed increased leptininduced anorexia and increased insulin sensitivity, suggesting that deletion of FOXO1 increased the responsiveness of SF1 neurons to both leptin and insulin [39] . Protein-tyrosine phosphatase 1B (PTP1B) is also an important negative regulator of leptin and insulin effects [40, 41] . In a recent study, PTP1B deletion in SF1 neurons (SF1-cre::Ptpn1 flox/flox ) resulted in an obese phenotype in HFD-fed female mice, which was associated with decreased energy expenditure and impaired sympathetic output [42] . They also found that SF1 neurons showed increased sensitivity to both leptin and insulin treatments in SF1-cre::Ptpn1 flox/flox mouse model [42] . As SF1 neuron-specific dominates to determine adiposity phenotypes. Although it is currently unclear why the influence of leptin or insulin effects on SF1 neurons is dominant over the other when common signaling molecules are engineered, localization of leptin and insulin signaling to distinct SF1 neurons of VMH may explain these findings.
CONCLUSIONS
The VMH occupies a large area within the mediobasal hypothalamus. While SF1 neurons within the VMH express the transcription factor SF1 and lack of SF1 results in obesity, these findings do not necessarily mean that all SF1 neurons are functionally homogeneous. In fact, it was previously shown that SF1 is expressed transiently by the developing hypothalamus including the ventrolateral subdivision of VMH (vlVMH). This expression is absent in vlVMH of adult mice [43] . These findings suggest that all VMH neurons require SF1 expression during development, but SF1 may be dispensable in adult vlVMH neurons. It was previously demonstrated that LepRs and InsRs have distinct metabolic function [5e7]. In the current study, we provided further evidence that SF1 neurons are heterogeneous in their acute response to leptin and insulin. We also demonstrated specificity in receptor-enzyme-target ion channel. Therefore, identification of more specific markers of subpopulations of SF1 cells will allow the functional characterization of distinct neuronal populations within the VMH. 
